(Q37104873)

18 August 2017

1 reference

title

Aortic sclerosis, aortic stenosis and lipid-lowering therapy (English)

1 reference

18 August 2017

0 references

1 reference

2

Helmut Baumgartner

1 reference

18 August 2017

1

Raphael Rosenhek

1 reference

18 August 2017

1 March 2008

1 reference

Expert Review of Cardiovascular Therapy

18 August 2017

1 reference

18 August 2017

6

1 reference

18 August 2017

3

1 reference

18 August 2017

385-390

1 reference

Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

18 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Rate of progression of valvular aortic stenosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Is aortic stenosis a preventable disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Diabetes and hypercholesterolemia among patients with calcific aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Development and progression of aortic valve stenosis: atherosclerosis risk factors--a causal relationship? A clinical morphologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Aortic valve calcification: determinants and progression in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Hypercholesterolemic aortic-valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

The value of percutaneous coronary intervention in aortic valve stenosis with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Mild and moderate aortic stenosis Natural history and risk stratification by echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.3.385

21 January 2018

Identifiers

DOI

10.1586/14779072.6.3.385

1 reference

18 August 2017

1 reference

PubMed ID

18327997